|

Hyperpolarized Carbon 13 Alpha-ketoglutarate (HP C13-aKG) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: HP C13-aKG, Hyperpolarized C13-aKG

Pipeline

Early 1: 1

Top Sponsors

  • Robert Bok, MD, PhD1

Indications

  • Adult Gliomas, Mixed1
  • Cancer1

San Francisco, California1 trial

Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma

University of California, San Francisco

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.